Personal Capital Advisors’s Charles River Laboratories CRL Stock Holding History

Personal Capital Advisors’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	$35M	Sell	160,483 -16,743	-9%	-$3.65M	0.17%	115
2022 Q3	$34.9M	Buy	177,226 +12,654	+8%	+$2.49M	0.19%	111
2022 Q2	$35.2M	Buy	164,572 +12,446	+8%	+$2.66M	0.18%	113
2022 Q1	$43.2M	Buy	152,126 +10,756	+8%	+$3.05M	0.2%	114
2021 Q4	$53.4M	Sell	141,370 -612	-0.4%	-$231K	0.25%	94
2021 Q3	$58.6M	Sell	141,982 -73,597	-34%	-$30.4M	0.29%	79
2021 Q2	$79.7M	Sell	215,579 -239	-0.1%	-$88.4K	0.41%	44
2021 Q1	$62.6M	Buy	215,818 +82	+0%	+$23.8K	0.36%	59
2020 Q4	$53.9M	Sell	215,736 -2,980	-1%	-$745K	0.34%	66
2020 Q3	$49.5M	Sell	218,716 -4,632	-2%	-$1.05M	0.37%	60
2020 Q2	$38.9M	Sell	223,348 -1,991	-0.9%	-$347K	0.32%	77
2020 Q1	$28.5M	Buy	225,339 +1,034	+0.5%	+$131K	0.28%	84
2019 Q4	$34.3M	Buy	224,305 +94,680	+73%	+$14.5M	0.29%	86
2019 Q3	$17.2M	Buy	129,625 +4,350	+3%	+$576K	0.16%	112
2019 Q2	$17.8M	Sell	125,275 -13,687	-10%	-$1.94M	0.18%	110
2019 Q1	$20.2M	Buy	138,962 +3,637	+3%	+$528K	0.23%	99
2018 Q4	$15.3M	Buy	135,325 +808	+0.6%	+$91.4K	0.21%	105
2018 Q3	$18.1M	Buy	134,517 +2,238	+2%	+$301K	0.23%	102
2018 Q2	$14.9M	Buy	132,279 +2,325	+2%	+$261K	0.21%	103
2018 Q1	$13.9M	Buy	129,954 +4,648	+4%	+$496K	0.22%	102
2017 Q4	$13.7M	Buy	125,306 +4,699	+4%	+$514K	0.23%	97
2017 Q3	$13M	Sell	120,607 -7,063	-6%	-$763K	0.25%	92
2017 Q2	$12.9M	Sell	127,670 -9,821	-7%	-$993K	0.28%	85
2017 Q1	$12.3M	Sell	137,491 -27,765	-17%	-$2.48M	0.31%	86
2016 Q4	$12.6M	Buy	165,256 +14,305	+9%	+$1.09M	0.37%	82
2016 Q3	$12.5M	Buy	150,951 +16,389	+12%	+$1.35M	0.42%	78
2016 Q2	$11.1M	Buy	134,562 +16,118	+14%	+$1.33M	0.43%	78
2016 Q1	$9M	Buy	118,444 +12,732	+12%	+$967K	0.41%	80
2015 Q4	$8.5M	Buy	105,712 +14,812	+16%	+$1.19M	0.47%	73
2015 Q3	$5.77M	Buy	90,900 +11,387	+14%	+$723K	0.38%	79
2015 Q2	$5.65M	Buy	+79,513	New	+$5.65M	0.39%	78